Search Results - Adriano Venditti

Refine Results
  1. 1
    Acute Lymphoblastic Leukemia Immunotherapy Treatment: Now, Next, and Beyond

    Acute Lymphoblastic Leukemia Immunotherapy Treatment: Now, Next, and Beyond by Anna Aureli, Beatrice Marziani, Adriano Venditti, Tommaso Sconocchia, Giuseppe Sconocchia

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    The Role of CPX-351 in the Acute Myeloid Leukemia Treatment Landscape: Mechanism of Action, Efficacy, and Safety

    The Role of CPX-351 in the Acute Myeloid Leukemia Treatment Landscape: Mechanism of Action, Efficacy, and Safety by Livio Pagano, Romano Danesi, E. Benedetti, Riccardo Morgagni, Luigina Romani, Adriano Venditti

    Published 2025
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management

    Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management by Maria Laura Evangelista, Elisa Stipa, Francesco Buccisano, Adriano Venditti, Sergio Amadori, Roberto Stasi

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    MRD in AML: The Role of New Techniques

    MRD in AML: The Role of New Techniques by Maria Teresa Voso, Tiziana Ottone, Serena Lavorgna, Adriano Venditti, Luca Maurillo, Francesco Lo‐Coco, Francesco Buccisano

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Challenges in Multiple Myeloma Therapy in Older and Frail Patients

    Challenges in Multiple Myeloma Therapy in Older and Frail Patients by Anna Aureli, Beatrice Marziani, Tommaso Sconocchia, Gianmario Pasqualone, Luca Franceschini, Giulio C. Spagnoli, Adriano Venditti, Giuseppe Sconocchia

    Published 2025
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making

    Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy deci... by Felicetto Ferrara, Giovanni Barosi, Adriano Venditti, Emanuele Angelucci, Marco Gobbi, Fabrizio Pane, Patrizia Tosi, Pier Luigi Zinzani, S Tura

    Published 2013
    Get full text Get full text
    Editorial
    Save to List
    Saved in:
  7. 7
    Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0)

    Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0) by Roberto Stasi, Giovanni Del Poeta, Adriano Venditti, M Masi, Elisa Stipa, T Dentamaro, Maria Christina Cox, Bruno Dallapiccola, Giuseppe Papa

    Published 1994
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma

    NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma by Andrea Coppola, Roberto Arriga, Davide Lauro, Maria Ilaria Del Principe, Francesco Buccisano, Luca Maurillo, Patrizia Palomba, Adriano Venditti, Giuseppe Sconocchia

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia

    Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia by Jorge E. Cortés, Marcos de Lima, Hervé Dombret, Elihu H. Estey, Sergio Giralt, Pau Montesinos, Christoph Röllig, Adriano Venditti, Eunice S. Wang

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Azacitidine for the treatment of lower risk myelodysplastic syndromes

    Azacitidine for the treatment of lower risk myelodysplastic syndromes by Pellegrino Musto, Luca Maurillo, Alessandra Spagnoli, Antonella Gozzini, Flavia Rivellini, Monia Lunghi, Oreste Villani, Maria Antonietta Aloe Spiriti, Adriano Venditti, Valeria Santini

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia

    Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia by Francesco Buccisano, Luca Maurillo, Maria Ilaria Del Principe, Giovanni Del Poeta, Giuseppe Sconocchia, Francesco Lo‐Coco, William Arcese, Sergio Amadori, Adriano Venditti

    Published 2011
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Complete remission induced by rituximab-lenalidomide, following CAR-T cell failure, is not associated with CAR-T cell re-expansion in the peripheral blood

    Complete remission induced by rituximab-lenalidomide, following CAR-T cell failure, is not associated with CAR-T cell re-expansion in the peripheral blood by Lucrezia De Marchi, Eugenio Galli, Patrizia Chiusolo, María Antonietta Irno Consalvo, Lucia Cardillo, Massimiliano Postorino, Adriano Venditti, Federica Sorà, Maria Christina Cox

    Published 2025
    Get full text
    Carta
    Save to List
    Saved in:
  13. 13
    Therapeutic Choice in Older Patients with Acute Myeloid Leukemia: A Matter of Fitness

    Therapeutic Choice in Older Patients with Acute Myeloid Leukemia: A Matter of Fitness by Raffaele Palmieri, Giovangiacinto Paterno, Eleonora De Bellis, Lisa Mercante, Elisa Buzzatti, Fabiana Esposito, Maria Ilaria Del Principe, Luca Maurillo, Francesco Buccisano, Adriano Venditti

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance

    FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance by Sara Caratelli, Tommaso Sconocchia, Roberto Arriga, Andrea Coppola, Giulia Lanzilli, Davide Lauro, Adriano Venditti, Maria Ilaria Del Principe, Francesco Buccisano, Luca Maurillo, Soldano Ferrone, Giuseppe Sconocchia

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia

    Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia by Giovanni Del Poeta, Roberto Stasi, Germano Aronica, Adriano Venditti, Maria Christina Cox, Antonio Bruno, Francesco Buccisano, M Masi, M Tribalto, Sergio Amadori, Giuseppe Francesco Sferrazza Papa

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib

    BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib by Isabella Faraoni, Mirco Compagnone, Serena Lavorgna, Daniela F. Angelini, Maria Teresa Cencioni, Eleonora Piras, Paola Panetta, Tiziana Ottone, Susanna Dolci, Adriano Venditti, Grazia Graziani, Francesco Lo‐Coco

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B‐cell chronic lymphocytic leukemia

    Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B‐cell chronic lymphocytic leukemia by Giovanni Del Poeta, Maria Ilaria Del Principe, Francesco Buccisano, Luca Maurillo, Giovanni Capelli, Fabrizio Luciano, Alessio Perrotti, Massimo Degan, Adriano Venditti, Paolo de Fabritiis, Valter Gattei, Sergio Amadori

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    18F-FDG PET/CT Radiomics for Predicting Therapy Response in Primary Mediastinal B-Cell Lymphoma: A Bi-Centric Pilot Study

    18F-FDG PET/CT Radiomics for Predicting Therapy Response in Primary Mediastinal B-Cell Lymphoma: A Bi-Centric Pilot Study by Fabiana Esposito, Luigi Manco, Luca Urso, Sara Adamantiadis, Giovanni Scribano, Lucrezia De Marchi, Adriano Venditti, Massimiliano Postorino, Nicoletta Urbano, Roberta Gafà, Antonio Cuneo, Agostino Chiaravalloti, Mirco Bartolomei, Luca Filippi

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Clinical significance of CD38 expression in chronic lymphocytic leukemia

    Clinical significance of CD38 expression in chronic lymphocytic leukemia by Giovanni Del Poeta, Luca Maurillo, Adriano Venditti, Francesco Buccisano, Anna Maria Epiceno, Giovanni Capelli, Anna Tamburini, Giovanna Suppo, Alessandra Battaglia, Maria Ilaria Del Principe, Beatrice Del Moro, Mario Masi, Sergio Amadori

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    <i>In vitro</i> elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumab

    <i>In vitro</i> elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumab by Sara Caratelli, Roberto Arriga, Tommaso Sconocchia, Alessio Ottaviani, Giulia Lanzilli, Donatella Pastore, Carlo Cenciarelli, Adriano Venditti, Maria Ilaria Del Principe, Davide Lauro, Elisa Landoni, Hongwei Du, Barbara Savoldo, Soldano Ferrone, Gianpietro Dotti, Giuseppe Sconocchia

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: